MADISON, Wis., Aug. 30, 2016 /PRNewswire/ -- Exact Sciences
Corp. (Nasdaq: EXAS) today announced that the company will
participate in Baird's 2016 Global Healthcare Conference.
Kevin Conroy, the company's
chairman and chief executive, will participate in a fireside chat
at the conference on Wednesday, Sept.
7 at 10:15 a.m. ET in
New York.
A live webcast of the fireside chat will be available through
the company's website at www.exactsciences.com. An archived
webcast will be available following the conclusion of the fireside
chat.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company
focused on the early detection and prevention of the deadliest
forms of cancer. The company has exclusive intellectual property
protecting its noninvasive, molecular screening technology for the
detection of colorectal cancer. Cologuard is included in the
American Cancer Society's (2014) colorectal cancer screening
guidelines and the recommendations of the U.S. Preventive Services
Task Force (2016). Stool DNA is included in the combined
screening guidelines of the American Cancer Society/U.S.
Multi-Society Task Force/American College of Radiology (2008) and
the American College of Gastroenterology guidelines (2009).
Certain statements made in this news release contain
forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of
the Securities and Exchange Act of 1934, as amended, that are
intended to be covered by the "safe harbor" created by those
sections. Forward-looking statements, which are based on certain
assumptions and describe the Company's future plans, strategies and
expectations, can generally be identified by the use of
forward-looking terms such as "believe," "expect," "may," "will,"
"should," "could," "seek," "intend," "plan," "estimate,"
"anticipate," or other comparable terms. Forward-looking statements
in this news release may address the following subjects among
others: the terms and size of the offering and the use of proceeds
from the offering. Forward-looking statements involve inherent
risks and uncertainties that could cause actual results to differ
materially from those in the forward-looking statements as a result
of various factors including those risks and uncertainties
described in the Risk Factors and in Management's Discussion and
Analysis of Financial Condition and Results of Operations sections
of the Company's most recently filed Annual Report on
Form 10-K and the Company's subsequently filed Quarterly
Reports on Form 10-Q. The Company urges you to consider those
risks and uncertainties in evaluating the Company's forward-looking
statements. The Company cautions readers not to place undue
reliance upon any such forward-looking statements, which speak only
as of the date made. Except as otherwise required by the federal
securities laws, the Company disclaims any obligation or
undertaking to publicly release any updates or revisions to any
forward-looking statement contained herein (or elsewhere) to
reflect any change in the Company's expectations with regard
thereto or any change in events, conditions or circumstances on
which any such statement is based.
Contact:
J.P.
Fielder
Senior Director, Corporate Communications, Exact Sciences Corp.
608-210-5220
jpfielder@exactsciences.com
Logo - http://photos.prnewswire.com/prnh/20160108/320353
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-the-baird-2016-global-healthcare-conference-300318918.html
SOURCE EXACT SCIENCES CORP